Immunome (IMNM)
NASDAQ:IMNM
US Market
Holding IMNM?
Track your performance easily

Immunome (IMNM) Ownership - Who Owns Immunome?

192 Followers

Immunome (IMNM) Ownership Overview

5.55%19.33%43.72%31.41%
43.72% Other Institutional Investors
31.41% Public Companies and
Individual Investors
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail and individual investors. Approximately 63.04% of the company’s stock is owned by Institutional Investors, 5.55% is owned by Insiders and 31.41% is owned by Public Companies and Individual Investors.
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail and individual investors. Approximately 63.04% of the company’s stock is owned by Institutional Investors, 5.55% is owned by Insiders and 31.41% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 19, 2024
xxxxxxxxxxxxx
$97580
Aug 19, 2024
xxxxxxxxxxxxx
$49054
May 22, 2024
xxxxxxxxxxxxx
$27120
May 21, 2024
Clay Siegall
President & Ceo,director
xxxxxxxxxxxxx
$1387344

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$3252480
Jun 30, 2024
xxxxxxxxxxxxx
$11166993

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,803,164Institution4.67%43,449,042
2,359,983Institution3.93%36,579,737
2,122,781Institution3.53%32,903,106
2,052,625Institution3.42%31,815,688
1,504,760Institution2.51%23,323,780
1,299,744Institution2.16%20,146,032
1,127,729Institution1.88%17,479,800
922,892Institution1.54%14,304,826
797,131Institution1.33%12,355,531
726,409Institution1.21%11,259,340

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,359,983Institution3.93%36,579,737
2,052,625Institution3.42%31,815,688
1,504,760Institution2.51%23,323,780
1,127,729Institution1.88%17,479,800
797,131Institution1.33%12,355,531
726,409Institution1.21%11,259,340
512,683Institution0.85%7,946,587
483,882Institution0.81%7,500,171
389,906Institution0.65%6,043,543
251,272Institution0.42%3,894,716

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,636,258Institution2.72%25,214,736
1,379,854Institution2.30%21,387,737
1,215,835Institution2.02%18,723,859
728,408Institution1.21%11,224,767
452,580Institution0.75%7,014,990
202,989Institution0.34%3,128,060
129,843Institution0.22%2,000,881
119,911Institution0.20%1,858,621
63,725Institution0.11%987,738
52,736Institution0.09%812,134

FAQ

Who Owns Immunome (IMNM)?
According to the latest TipRanks data, approximately 43.72% of the company's stock is held by institutional investors, 5.55% is held by insiders, and 31.41% is held by retail investors.
    What percentage of Immunome (IMNM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 43.72% of Immunome (IMNM) stock is held by institutional investors.
      What percentage of Immunome (IMNM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 31.41% of Immunome (IMNM) stock is held by retail investors.
        Who owns the most shares of Immunome (IMNM)?
        Vanguard owns the most shares of Immunome (IMNM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis